［1］Jan Martel，Hsin-Hsin Peng，David Young，et al.Of nanobacteria，nano-particles，biofilms and their role in health and disease：facts，fancy and future［J］.Nanomedicine，2014，9(4)：483-499.
［2］Kajander EO，Kuronen I，Akerman K，et al.Nanobacteria from blood，the smallest culturable autonomously replicating agent on earth［J］.Proc.Soc.Photo Opt.Instrum.Eng，1997，31(11)：420-428.
［3］Kajander EO，Ciftcioglu N.Nanobacteria：an alternative mechanism for pathogenic intra-and extracellular calcifcation and stone formation［J］.Proc Natl Acad Sci USA，1998，95(14)：8274-8279.
［4］Wang Limin，Shen Wenlv，Wen Jun，et al.An animal model of black pigment gallstones caused by nanobacteria［J］.Digestive Diseases & Sciences，2006，51(6)：1126-1132.
［5］Hu WG，Wang XF，Xu T，et al.Establishment nephrolithiasis rat model induced by nanobacteria and analysis of stone formation ［J］.Revuede Philosophie，2010，42(4)：433-436.
［6］Ciftcioglu N，Kajander EO.Interaction of nanobacteria with cultured mamm-alian cells［J］ Pathophysiology，1998，4(4)：259-270.
［7］Martel J，Wu CY，Huang PR，et al.Pleomorphic bacteria-like structures in human blood represent non-living membrane vesicles and protein particles［J］.Sci Rep，2017，7(1)：10650-10651.
［8］Igor Jerman.What nanobacteria and nanovesicles may tell us about the origin of life? ［J］.Open Access Library Journal，2017，4(1)：1-13.
［9］Wong TY，Wu CY，Martel J，et al.Detection and characterization of mineralo-organic nanoparticles in human kidneys［J］.Sci.Rep.，2015，5(5)：152-172.
［10］Martel J，Wu CY，Young JD.Translocation of mineralo-organic nanoparticles from blood to urine：a new mechanism for the formation of kidney stones? ［J］.Nano-medicine，2016，11(18)：2399-2404.
［11］John D Young，Jan Martel，David Young，etal.Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria［J］.PLoS One，2009，4 (5)：5421-5423.
［12］John D Young，Jan Martel，Lena Young，et al.Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis［J］.PLoS One，2009，4(2)：4417-4451.
［13］Hjelle JT，Miller Hjelle MA，Poxton IR，et al.Endotoxin and nanobacteria in polycystic kidney disease［J］.Kidney Int，2000，57(6)：2360-2374.
［14］Wong TY，Peng HH，Wu CY.et al.Nanoparticle conversion to biofilms：in vitro demonstration using serum derived mineralo-organic nanoparticles［J］.Nanomedicine，2015，10(24)：3519-3535.
［15］Lydia Shook，Catalin Buhimschi，Antonette Dulay，et al.Calciprotein particles as potential etiologic agents of idiopathic preterm birth［J］.Sci Transl Med，2016，8(364)：364-374.
［16］Smith ER，Hewitson TD，Cai MMX，et al.A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum［J］.Sci.Rep.2017，7(1)：56-66.
［17］Cheng-Yeu Wu，Jan Martel，Wei-Yun Cheng.et al.Membrane vesicles nucleate mineralo organic nanoparticles and induce carbonate apatite precipitation in human body fluids［J］.J Biol Chem，2013，288(42)：30571-30584.
［18］Ansari H，Akhavan Sepahi A，Akhavan Sepahi M.Different approaches to detect “nanobacteria” in patients with kidney stones：an infectious cause or a subset of life［J］.Urol J，2017，14(5)：5001-5007.
［19］Richards JM，Kunitake J，Hunt HB，et al.Crystallinity of hydroxyapatite drives myofibroblastic activation and calcification in aortic valves［J］.Acta Biomater，2018，71(1)：24-36.
［20］Sommer AP.Could reduced bone mineral densities in HIV be caused by nanobacteria?［J］.J Proteome Res，2004，3(3)：670-672.
［21］张名均，傅长虹，张德纯.纳米细菌对人成骨细胞C3H10的细胞毒作用［J］.中国微生态学杂志，2015，27(1)：14-18.
［22］郭亚楠，张名均，张德纯，等.钙化胎盘中纳米细菌的分离培养与鉴定［J］.中国微生态学杂志，2010，22(12)：1097-1100.
［23］Tsurumoto T，Matsumoto T，Yonekura A，et al.Nanobacteria like particles in human arthritic synovial fluids［J］.Proteome Res，2006，5(5)：1276-1278.
［24］彭伟秋，李永国，张湘生，等.人膝骨关节炎患者关节液中纳米细菌检测及其对软骨细胞生物学形状的影响和机制探讨［C］长沙：中南大学，2007.
［25］Tsurumoto T，Zhu D，Sommer AP.Identification of nanobacteria in human arthritic synovial fluid by method validated in human blood and urine using 200 nm model nanoparticles［J］.Environ Sci Technol，2008，42(9)：3324-3328.
［26］Rachit Agarwal，Tiago M Volkmer，Peiyi Wang，et al.Synthesis of self assembled IL-1Ra-presenting nanoparticles for the treatment of osteoarthritis［J］.J Biomed Mater Res A，2016，104(9)：595-599.
［27］石庆新，於青峰，涂茜，等.类风湿关节炎患者血清中纳米细菌检测及鉴定［J］.中国现代医生，2013，51(2)：85-86.
［28］石庆新，陆如岳，於青峰.纳米细菌感染在类风湿关节炎中致病作用研究［J］.中国卫生检验杂志，2013，23(4)：884-886.
［29］Olszta MJ，Cheng X，Soo Jee S，et al.Bone structure and formation：a new perspective［J］.Mater Sci Eng，2007，58(35)：77-116.
［30］Bongio M，Lopa S，Gilardi M，et al.A 3D vascularized bone remodeling model combining osteoblasts and osteoclasts in a CaP nanoparticle-enriched matrix［J］.Nanomedicine，2016，11(9)：1073-1091.
［31］Orriss Isabel R，Arnett Timothy R，Russell R Graham G.Pyrophosphate：a key inhibitor of mineralisation［J］.Curr Opin Pharmacol，2016，28(1)：57-68.
［32］Wu CY，Martel J，Young D，et al.Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria：demonstration of a dual inhibition-seeding concept［J］.PLoS One，2009，4(11)：8058-8107.
［33］Pasch A.Novel assessments of systemic calcification propensity［J］.Curr Opin Nephrol Hypertens，2016，25(4)：278-284.
［34］Martel Jan，Wu Cheng-Yeu，Peng Hsin-Hsin.Mineralo-organic nanoparticles in health and disease：an overview of recent findings［J］.Nanomedicine，2018，13(14)：108-116.
晋公网安备 14010702070875号